1. 1575. Clinical Validation of a Novel ELISpot-based in vitro Diagnostic Assay to Monitor CMV-Specific Cell-Mediated Immunity in SOT and HSCT Immunocompromised Patients. (26th November 2018) Authors: Banas, Bernhard; Steubl, Dominik; Renders, Lutz; Chittka, Dominik; Banas, Miriam; Wekerle, Thomas; Koch, Martina; Witzke, Oliver; Lindemann, Monika; Muehlfeld, Anja; Sommerer, Claudia; Habicht, Antja; Hugo, Christian; Huenig, Thomas; Mielke, Stephan; Schreder, Martin; Wagner, Eva; Teschner, Danie... Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S491 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cyclophosphamide plus etoposide is a safe and effective mobilization regimen in patients with multiple myeloma. (October 2021) Authors: Heider, Michael; Grass, Sandra; Dill, Veronika; Rämisch, Stephanie; Winter, Christof; Verbeek, Mareike; Götze, Katharina S.; Bassermann, Florian; Jilg, Stefanie Journal: Transfusion and apheresis science Issue: Volume 60:Number 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial. Issue 1 (January 2020) Authors: Beelen, Dietrich Wilhelm; Trenschel, Rudolf; Stelljes, Matthias; Groth, Christoph; Masszi, Tamás; Reményi, Péter; Wagner-Drouet, Eva-Maria; Hauptrock, Beate; Dreger, Peter; Luft, Thomas; Bethge, Wolfgang; Vogel, Wichard; Ciceri, Fabio; Peccatori, Jacopo; Stölzel, Friedrich; Schetelig, Johannes; J... Journal: Lancet Issue: Volume 7:Issue 1(2020) Page Start: e28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗